BioSpace News Archive

Veteran Biopharmaceutical Executive and Cancer Researcher Brings Extensive Clinical Development and Medical Affairs Experience to Salarius’ Seclidemstat Program

The Chief Executive Officer for BetterLife Pharma Inc. (OTCQB:BETRD) (CSE:BETR), an emerging biotechnology company currently preparing its own interferon-based coronavirus treatment clinical trials, recently joined online portal Proactive for a Q&A which included the upcoming merger with Altum Pharmaceuticals, interferon inhalation treatment for COVID-19,

Collaboration focused on developing an adjuvanted COVID-19 vaccine using Medigen’s subunit vaccine candidate with Dynavax’s CpG 1018 In preclinical testing, the combination generated strong virus neutralizing antibody responses Medigen anticipates initiating a Phase 1 clinical trial evaluating the combination in September 2020

Clinical hold lifted on seladelpar INDs in NASH, PBC and PSC Re-initiating clinical development focusing first on Phase 3 for PBC

InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announced it has obtained registration from the Brazilian registration authority, Agéncia Nacional de Vigiláncia Sanitária (ANVISA), for its CGuard™ MicroNet ® - covered stent, clearing it for sale and distribution in Brazil. “As the largest market for medical devices i

Astellas & Golden Ticket; sponsorship provides access to life-science incubator and in-house Astellas expertise for scientific entrepreneurs with cutting-edge ideas

Today, the Craig H. Neilsen Foundation, the largest private funder of spinal cord injury research, education, clinical training and programmatic support in the U.S. and Canada, announced that it has allocated close to $10 million in emergency grant funding to support the spinal cord injury (SCI) community and critical research amid the COVID-19 pandemic.

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company” or “Ampio”), is a biopharmaceutical company focused on the development and advancement of immunology-based therapies for prevalent inflammatory conditions. As part of this program, the Company is actively working on the development of therapies for patients infected wi

Beckman Coulter today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its PK7400 Automated Microplate System and the system’s reagents have completed FDA approval.

Qualtrics, the leader in customer experience and creator of the experience management (XM) category, today announced it is an approved vendor for the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey. Hospitals can now view their HCAHPS results alongside their real-time data in the Qualtrics XM Platform™,